Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
about
Viruses associated with human cancerHepatocellular carcinoma and hepatitis B surface proteinStudy of transactivating effect of pre-S2 protein of hepatitis B virus and cloning of genes transactivated by pre-S2 protein with suppression subtractive hybridization.Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.Transfusion transmitted virus: A review on its molecular characteristics and role in medicine.The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice.Incidence of HBV variants with a mutation at nt551 among hepatitis B patients in Nanjing and its neighbourhood.Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinomaHepatitis B virus mutants: an overview.HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinomaHCC-Associated Single Nucleotide Variants and Deletions Identified Using Genome-Wide High Throughput Analysis of HBV.Occult hepatitis B in blood donors: a description of two cases.Quantitative and genotypic analysis of TT virus infection in Chinese blood donors.A mutation specific polymerase chain reaction for detecting hepatitis B virus genome mutations at nt551.Molecular, immunological and clinical properties of mutated hepatitis B viruses.Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc.Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients.
P2860
Q24653900-A80969F8-1B50-442E-8144-71ED209B1AB9Q26766123-3CD3D6B9-7EAA-44AB-9E5E-C49D6FB97AA1Q30864670-DF7E34A3-2E62-49CF-B50B-2CDFBE77C456Q31161563-3C6127BD-7106-4118-B606-55F8B1248D2EQ33868591-80BB9EEE-2492-47FB-9AE1-E801C80D87EFQ34085793-48ED96F8-5AD2-4D85-BE59-01E468BF7680Q34382741-8488AA81-2187-46A7-9BBC-128821BE23C0Q34605140-D1A1578F-0093-48F8-9AB6-F133838842DEQ35048277-7BAF1095-C638-455C-962A-76D7D3099C8AQ36557209-F510596D-B94A-4B0F-B61E-FAD4B7C1AC2CQ39428108-8B0E9979-5AF6-4782-8467-0652D372E722Q41774248-9D38B8B2-2A4F-4619-AC1B-B60008929D79Q42656428-CE5C98B2-FD55-48DC-B879-BC3C4B957C93Q43201105-D9CE48FF-724E-4B9B-B2E1-75A28B58DAFDQ43988430-5964DB5A-82C7-4965-ACEB-6355E6A7BF3FQ45729490-75D099B3-3C6E-4DED-9C16-561CB5053316Q45734082-B568281F-6744-41AD-8757-212A5A1D7A6C
P2860
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
@en
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
@nl
type
label
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
@en
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
@nl
prefLabel
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
@en
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
@nl
P2093
P2860
P1476
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2893.1999.00154.X
P577
1999-05-01T00:00:00Z